Sandoz Group AG in 2 stories
The narratives SDZ.SW currently appears in, with its side and exposure in each.
Bull side
2 stories- America Imports the World's Drug Prices
SDZ.SW in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Reference pricing increases demand for biosimilars and generics that can establish a defensible lower-cost benchmark.
- The Patent Cliff Sparks a Biotech Land Grab
SDZ.SW in “The Patent Cliff Sparks a Biotech Land Grab”
FadingExposure: not rated yetLarge drugmakers facing revenue holes must buy scarce pipelines, turning clinical validation into strategic currency.
Sandoz can monetize the other side of the patent cliff through biosimilars and complex generics as blockbuster biologics lose exclusivity.
Bear side
0 storiesNo bear-side stories for SDZ.SW yet.